Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chugai And Riken Bio Venture Company To Research Antibody Drugs

This article was originally published in PharmAsia News

Executive Summary

Chugai Pharmaceutical and Chiome Bioscience, a biopharmaceutical venture company established by Riken Institute, announced Dec. 3 that the two will jointly identify monoclonal antibodies against multiple targets selected from a series of disease-associated proteins provided by Chugai. The research will use an autonomously diversifying library system developed by Chiome. Chugai will give Chiome a undisclosed one-time payment and milestone compensations according to research results. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts